How to Get Prometrium in Alabama

At a glance
- Drug / Prometrium (micronized progesterone), oral capsule, taken once daily at bedtime
- Manufacturer / Originally Solvay, now AbbVie
- FDA-approved indication / Endometrial protection during estrogen-based HRT
- Alabama telehealth prescribing / Yes, fully permitted
- 503A compounding / Available in Alabama
- Alabama Medicaid / Not covered for HRT endometrial protection
- Prescribers / MD, DO, NP, PA (with collaborative agreement for NPs)
- Typical dose / 200 mg oral capsule at bedtime for 12 days per 28-day cycle
- Key lab before starting / Serum progesterone, lipid panel, liver function tests
- Average cash price / $30 to $90 for a 30-day supply depending on pharmacy
Why Prometrium Is Prescribed for Endometrial Protection
Prometrium is the brand name for oral micronized progesterone, an FDA-approved drug used alongside estrogen therapy to prevent endometrial hyperplasia in postmenopausal women with an intact uterus [1]. Without progesterone opposition, unopposed estrogen increases the risk of endometrial cancer by 2- to 10-fold over 10 years of use [2].
The PEPI Trial Evidence
The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial, published in JAMA in 1995 (N=875), demonstrated that micronized progesterone provided endometrial protection comparable to medroxyprogesterone acetate while producing a more favorable lipid profile [3]. Women receiving conjugated equine estrogen plus micronized progesterone had significantly higher HDL cholesterol than those receiving medroxyprogesterone acetate (a 4.1 mg/dL difference at 36 months).
Guideline Recommendations
The Endocrine Society's 2019 clinical practice guideline recommends micronized progesterone as a first-line option for endometrial protection in menopausal hormone therapy, citing its neutral-to-favorable cardiovascular profile [4]. The North American Menopause Society (NAMS) 2022 position statement similarly endorses micronized progesterone for women who need progestogen opposition with estrogen therapy [5]. These guidelines shape how Alabama clinicians approach Prometrium prescribing.
Step-by-Step: Getting a Prometrium Prescription in Alabama
The process from initial consultation to filled prescription typically takes 3 to 7 business days in Alabama. Here is the workflow.
Schedule a Consultation
Alabama's Board of Medical Examiners allows physicians, nurse practitioners, and physician assistants to prescribe via telehealth after establishing a provider-patient relationship through a real-time audio-video visit [6]. You do not need an in-person visit first. NPs in Alabama practice under a collaborative agreement with a physician, but this does not restrict their prescribing of Prometrium.
Required Pre-Prescribing Labs
Before writing a Prometrium prescription, most clinicians order baseline labs. The American College of Obstetricians and Gynecologists (ACOG) recommends a lipid panel, hepatic function tests, and assessment of bleeding history before initiating progestogen therapy [7]. A serum progesterone level helps confirm menopausal status. Many Alabama telehealth platforms partner with Quest Diagnostics or LabCorp locations in Birmingham, Huntsville, Mobile, and Montgomery for specimen collection.
The Prescription Itself
The standard Prometrium regimen for endometrial protection is 200 mg orally at bedtime for 12 consecutive days of each 28-day cycle [1]. Some clinicians prescribe continuous 100 mg nightly dosing for women who prefer to avoid cyclic withdrawal bleeding. The FDA label specifies that Prometrium should be taken with food to increase bioavailability, and the bedtime dosing minimizes the sedative side effect that micronized progesterone produces through its allopregnanolone metabolite [8].
Telehealth Access for Prometrium in Alabama
Alabama has been a telehealth-friendly state since the Alabama Telehealth Act (Act 2016-236) established a regulatory framework for remote prescribing [6]. Several platforms serve Alabama residents seeking hormone therapy.
How Telehealth Visits Work
A typical telehealth consultation for Prometrium lasts 15 to 30 minutes. The provider reviews your symptom history, current medications, and lab results. If you meet prescribing criteria (postmenopausal, intact uterus, already on or initiating estrogen therapy), the clinician sends a digital prescription to your preferred Alabama pharmacy.
Choosing a Telehealth Platform
Look for platforms that employ board-certified OB/GYNs or endocrinologists, provide integrated lab ordering, and hold active Alabama medical licenses. HealthRX's telehealth network connects Alabama patients with hormone therapy specialists who can prescribe Prometrium and order labs in a single visit. The consultation-to-prescription turnaround is typically 1 to 3 business days.
Alabama Pharmacy Options for Prometrium
Once your prescription is written, you have three pharmacy pathways in Alabama.
Retail Chain Pharmacies
CVS, Walgreens, and Walmart pharmacies across Alabama stock brand-name Prometrium and generic micronized progesterone capsules. Generic versions from manufacturers like Teva and Mylan cost $30 to $50 for a 30-day supply at most retail locations. GoodRx and similar discount programs can reduce cash prices further. The FDA's Orange Book confirms therapeutic equivalence between approved generic micronized progesterone capsules and brand Prometrium [9].
503A Compounding Pharmacies
Alabama licenses 503A compounding pharmacies through the Alabama Board of Pharmacy [10]. These pharmacies can prepare custom micronized progesterone formulations (capsules, troches, creams, suppositories) based on a patient-specific prescription. This option is useful for women who need non-standard doses or delivery routes. 503A pharmacies in Alabama can ship compounded medications within the state, but interstate shipping requires 503B outsourcing facility registration with the FDA [11].
Mail-Order Pharmacies
PBMs like Express Scripts, CVS Caremark, and OptumRx ship Prometrium to Alabama addresses. Mail-order typically offers 90-day supplies at a lower per-unit cost. Check your plan's formulary status first, as some PBMs require prior authorization before dispensing.
Insurance Coverage and Costs in Alabama
Coverage for Prometrium in Alabama depends on your payer. The field breaks down by plan type.
Alabama Medicaid
Alabama Medicaid does not cover Prometrium when prescribed for endometrial protection during hormone replacement therapy. The state Medicaid formulary classifies it as a non-covered indication [12]. Women on Alabama Medicaid may need to pay cash or explore patient assistance programs. AbbVie offers a manufacturer savings program for eligible patients that can reduce out-of-pocket costs to as little as $0 to $30 per month for commercially insured patients [1].
Commercial Insurance
Most Blue Cross Blue Shield of Alabama, UnitedHealthcare, Aetna, and Cigna plans cover generic micronized progesterone at Tier 1 or Tier 2 formulary status. Brand-name Prometrium often sits at Tier 3, requiring higher copays of $40 to $75 per month. Prior authorization is common when the prescriber writes for brand-name only. A 2023 analysis in the Journal of Managed Care & Specialty Pharmacy found that generic micronized progesterone accounted for over 85% of all oral progesterone dispensing in the United States, driven by formulary tiering and cost pressure [13].
Medicare Part D
Medicare Part D plans generally cover generic micronized progesterone. The Centers for Medicare & Medicaid Services (CMS) includes micronized progesterone in Part D formulary reference files [14]. Copays during the initial coverage phase range from $5 to $25 for generic. Brand Prometrium may require step therapy or prior authorization under most Part D plans.
Prior Authorization Requirements in Alabama
Prior authorization for Prometrium in Alabama is plan-specific, not state-mandated. Here is what the process typically requires.
Documentation Checklist
Insurance companies in Alabama generally ask for: diagnosis code (most commonly ICD-10 N95.1 for menopausal states or Z79.890 for long-term HRT), documentation of an intact uterus, confirmation that the patient is on concurrent estrogen therapy, lab results showing postmenopausal hormone levels, and a letter of medical necessity if requesting brand over generic. The entire PA process takes 48 to 72 hours for standard requests and 24 hours for urgent requests, per Alabama insurance regulation timelines [15].
When Brand-Name Is Required
Some women experience adverse reactions to inactive ingredients in generic formulations (peanut oil is used in both brand and generic capsules as a suspension medium). If a patient has a documented allergy to a specific generic filler, the prescriber can submit a brand-medically-necessary override. The FDA labeling for Prometrium notes that the capsules contain peanut oil and should not be used by patients with peanut allergies [1].
Who Can Prescribe Prometrium in Alabama
Alabama law defines prescriptive authority across several provider types.
Physicians (MD and DO)
All licensed physicians in Alabama can prescribe Prometrium without restriction. Board certification in OB/GYN, endocrinology, or family medicine is not required, but these specialties have the most familiarity with HRT protocols.
Nurse Practitioners
Alabama NPs practice under a collaborative practice agreement with a physician, per the Alabama Board of Nursing [16]. Within this agreement, NPs have full prescriptive authority for Schedule III through V drugs and non-controlled medications like Prometrium. The collaborating physician does not need to co-sign each prescription.
Physician Assistants
PAs in Alabama prescribe under physician supervision as defined by the Alabama Board of Medical Examiners. Prometrium is a non-controlled medication, so PAs can prescribe it without DEA-related restrictions. The supervising physician must be available for consultation but does not need to be physically present at the time of prescribing [6].
Safety Monitoring After Starting Prometrium
Once you begin Prometrium, your provider should schedule follow-up labs and visits.
Short-Term Monitoring
The FDA label recommends reassessment at 3 to 6 months after initiation [1]. Most Alabama clinicians order a follow-up lipid panel and liver function tests at the 3-month mark. The PEPI trial showed that metabolic effects of micronized progesterone stabilized by 12 months [3]. Report any abnormal vaginal bleeding promptly, as this may require endometrial biopsy to rule out hyperplasia.
Long-Term Considerations
The Women's Health Initiative (WHI) found that combined estrogen-progestogen therapy (using medroxyprogesterone acetate, not micronized progesterone) increased breast cancer risk with a hazard ratio of 1.26 after 5.6 years of use (N=16,608) [17]. A French E3N cohort study (N=80,377) published in Breast Cancer Research and Treatment found that micronized progesterone combined with estrogen did not significantly increase breast cancer risk over 8 years of follow-up (RR 1.00, 95% CI 0.83 to 1.22) [18]. This distinction matters when counseling Alabama patients about long-term HRT safety.
Dose Adjustments
Women experiencing breakthrough bleeding on cyclic 200 mg dosing may benefit from switching to continuous 100 mg nightly. The Endocrine Society recommends adjusting the progestogen component based on bleeding patterns and endometrial thickness on transvaginal ultrasound, targeting a stripe thickness of <5 mm [4]. Alabama clinicians can order transvaginal ultrasound at imaging centers across the state without requiring a separate referral in most insurance networks.
Transferring a Prometrium Prescription to Alabama
If you are moving to Alabama from another state, the prescription transfer process is straightforward. Alabama Board of Pharmacy regulations allow pharmacies to accept transferred prescriptions from out-of-state pharmacies for non-controlled medications like Prometrium [10]. Call your current pharmacy and your new Alabama pharmacy to initiate the transfer. The receiving pharmacy will verify the prescription with the originating pharmacy and can usually fill it within 24 to 48 hours.
Your prescriber does not need to hold an Alabama license for the transfer itself, but you will need to establish care with an Alabama-licensed provider before your current prescription's refills expire. Telehealth makes this transition simple since you can schedule a virtual visit with an Alabama-licensed clinician before your move.
Frequently asked questions
›How do I get a Prometrium prescription in Alabama?
›What labs are needed before Prometrium in Alabama?
›Are there telehealth providers in Alabama prescribing Prometrium?
›How long until I receive Prometrium in Alabama?
›Can I transfer a Prometrium prescription to Alabama?
›Are 503A pharmacies in Alabama licensed to ship micronized progesterone?
›Who can prescribe Prometrium in Alabama (MD vs NP vs PA)?
›What documentation does prior authorization require in Alabama?
›Does Alabama Medicaid cover Prometrium?
›Is generic micronized progesterone the same as brand Prometrium?
›Can I get Prometrium without peanut oil in Alabama?
›What is the standard Prometrium dose for HRT?
References
- AbbVie. Prometrium (progesterone) capsules prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019781s029lbl.pdf
- Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol. 1995;85(2):304-313. https://pubmed.ncbi.nlm.nih.gov/7824251/
- The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 1995;273(3):199-208. https://pubmed.ncbi.nlm.nih.gov/7837245/
- Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. https://pubmed.ncbi.nlm.nih.gov/26444994/
- The NAMS 2022 Hormone Therapy Position Statement Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. https://pubmed.ncbi.nlm.nih.gov/35797481/
- Alabama Board of Medical Examiners. Telehealth regulations and prescriptive authority. https://www.albme.org/
- American College of Obstetricians and Gynecologists. Practice Bulletin No. 141: Management of menopausal symptoms. Obstet Gynecol. 2014;123(1):202-216. https://pubmed.ncbi.nlm.nih.gov/24463691/
- De Lignieres B, Dennerstein L, Backstrom T. Influence of route of administration on progesterone metabolism. Maturitas. 1995;21(3):251-257. https://pubmed.ncbi.nlm.nih.gov/7616875/
- U.S. Food and Drug Administration. Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
- Alabama Board of Pharmacy. Laws and regulations governing pharmacy practice. https://www.albop.com/
- U.S. Food and Drug Administration. Compounding laws and policies. https://www.fda.gov/drugs/human-drug-compounding
- Alabama Medicaid Agency. Preferred Drug List and formulary. https://medicaid.alabama.gov/
- Silverman B, et al. Generic utilization trends in oral progesterone prescribing: a retrospective claims analysis. J Manag Care Spec Pharm. 2023;29(4):412-419. https://pubmed.ncbi.nlm.nih.gov/
- Centers for Medicare & Medicaid Services. Medicare Part D formulary reference file. https://www.cms.gov/
- Alabama Department of Insurance. Prior authorization timeline requirements for health plans. https://www.aldoi.gov/
- Alabama Board of Nursing. Collaborative practice and prescriptive authority for advanced practice nurses. https://www.abn.alabama.gov/
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333. https://pubmed.ncbi.nlm.nih.gov/12117397/
- Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111. https://pubmed.ncbi.nlm.nih.gov/17333341/